Riikka Erkkilä

Title: Riikka Erkkilä: Innovator in Gastrointestinal Health

Introduction

Riikka Erkkilä is a notable inventor based in Turku, Finland. She has made significant contributions to the field of medical diagnostics, particularly in the area of gastrointestinal health. Her innovative approach has led to the development of a patented method that aids in the determination of inflammatory gastrointestinal tract diseases.

Latest Patents

Riikka holds a patent for a method that determines the likelihood of an inflammatory gastrointestinal tract disease. This method involves diluting a biological sample from a human subject and using 8-anilinonaphthalene-1-sulfonic acid as a modulating agent. The sample is then treated with a reagent that includes a peroxidase enzyme and a label, such as europium chloride or terbium chloride. After incubation and excitation, the time-resolved luminescence signal of the label is measured. If the luminescence signal is at least 112% higher than that of a control sample from a healthy individual, it indicates an increased likelihood of an inflammatory intestinal disease.

Career Highlights

Riikka is currently associated with Aqsens Health Oy, where she continues to work on innovative solutions in health diagnostics. Her expertise and dedication to research have positioned her as a key player in her field.

Collaborations

Throughout her career, Riikka has collaborated with talented professionals, including Janne Kulpakko and Anita Jansen. These collaborations have further enhanced her research and development efforts.

Conclusion

Riikka Erkkilä's contributions to the field of gastrointestinal health through her innovative patent demonstrate her commitment to advancing medical diagnostics. Her work continues to impact the healthcare industry positively.